<DOC>
	<DOCNO>NCT02853214</DOCNO>
	<brief_summary>Multiple Myeloma ( MM ) malignant proliferation monoclonal plasma cell . Myeloma account almost 14 % hematologic cancer essentially incurable . Myeloma commonly evolve precursor disease , Monoclonal gammopathy undetermined significance ( MGUS ) . Despite intensive study , etiology MGUS myeloma unknown lifestyle environmental exposure factor identify consistently link increase risk MM , MGUS transition two . The overall goal identify risk gene dysglobulinemia , specifically Multiple Myeloma . This involve conservation cell bank genetic sequencing sample obtain family least two case dysglobulinemia . Material use sequence likely include fresh peripheral blood cell lymphoblastoid line establish peripheral blood lymphocytes patient .</brief_summary>
	<brief_title>Familial Dysglobulinemia</brief_title>
	<detailed_description />
	<criteria>2 case per family least 1 case alive least biological material available 1 case least Patients give informed consent attach French Health protection service Age 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Dysglobulinemia</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>MGUS</keyword>
	<keyword>Waldenstr√∂m</keyword>
	<keyword>genetic factor</keyword>
	<keyword>Sequencing</keyword>
</DOC>